-

REMINDER: FS KKR Capital Group Investors With Significant Losses Must Act By July 6, 2026

NEW YORK--(BUSINESS WIRE)--Kirby McInerney LLP reminds FS KKR Capital Group (“FS KKR Capital” or the “Company”) (NYSE:FSK) investors of the July 6, 2026 deadline to seek the role of lead plaintiff in a pending federal securities class action. Courts do not consider applications filed after this deadline. The lead plaintiff oversees the litigation on behalf of the class and may influence key decisions, including litigation strategy and settlement. Courts regularly appoint individual investors as lead plaintiffs, not only institutions.

If you purchased or otherwise acquired FS KKR Capital securities, have information, or would like to learn more, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the form below, to discuss your rights or interests.

[CONTACT THE FIRM IF YOU SUFFERED A LOSS]

What Is The Lawsuit About?

The lawsuit has been filed on behalf of investors who purchased securities during the period of May 8, 2024 through February 25, 2026, inclusive (“the Class Period”). The lawsuit alleges that FS KKR Capital overstated (1) the effectiveness of its portfolio restructuring efforts for its nonaccrual companies; (2) the valuation of its portfolio investments and/or overstated the effectiveness of its portfolio valuation process; and (3) the durability of its quarterly distribution strategy.

On August 6, 2025, FS KKR Capital reported Q2 2025 earnings, revealing that its net asset value had declined to $21.93 per share, down $1.44 per share, or 6.2%, from the prior quarter, and the total fair value of investments fell $474 million. The Company also reported earnings (loss) per share of negative $0.75, down $1.18 per share, or 274%, from the prior quarter. On this news, the price of FS KKR Capital shares declined by $1.66 per share, or approximately 8%, from $20.24 per share on August 6, 2025 to close at $18.58 on August 7, 2025.

Then, on February 25, 2026, FS KKR Capital reported Q4 and full year 2025 earnings, revealing net asset value had continued to decline to $20.89 per share, down $1.10 per share, or 5%, from the prior quarter, and the total fair value of investments fell another $406 million. The Company reported earnings (loss) per share of negative $0.41, down $1.17 per share, or 154%, from the prior quarter. FS KKR Capital also “acknowledge[d] specific challenges” with additional companies in its portfolio and cut its dividend to $0.48 per share (previously $0.70). On this news, the price of FS KKR Capital shares declined by $2.03 per share, or approximately 15%, from $13.32 per share on February 25, 2026 to close at $11.29 on February 26, 2026.

[CLICK HERE TO LEARN MORE ABOUT THE CLASS ACTION]

What Should I Do?

If you purchased or otherwise acquired FS KKR Capital securities, have information, or would like to learn more about this investigation, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests with respect to these matters at no cost.

[WHAT IS A SECURITIES CLASS ACTION?]

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Kirby McInerney LLP

NYSE:FSK

Release Versions

Contacts

More News From Kirby McInerney LLP

UNCY INVESTOR ALERT: Securities Class Action Filed Against Unicycive Therapeutics, Inc. – Investors Encouraged to Contact Kirby McInerney LLP

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Unicycive Therapeutics (“Unicycive” or the “Company”) (NASDAQ: UNCY) securities during the period of December 29, 2025 through June 29, 2026, inclusive (“the Class Period”). Investors are encouraged to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or...

DKS SHAREHOLDER ALERT: Dick’s Sporting Goods, Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Dick’s Sporting Goods, Inc. (“Dick’s” or the “Company”) (NYSE: DKS) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.[LEARN MORE ABOUT THE INVESTIGATION]What Happened?On August 24, 2026, Dick’s reported its second quarter 2026 financial results, revealing a net income o...

GDDY INVESTOR REMINDER: GoDaddy Inc. Investors Have Until October 20, 2026 To Contact Kirby McInerney LLP to Seek Lead Plaintiff Role

NEW YORK--(BUSINESS WIRE)--If you have suffered a loss on your GoDaddy Inc. (“GoDaddy” or the “Company”) (NYSE: GDDY) investment, contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost. Investors have until October 20, 2026 to ask the Court to appoint them as lead plaintiff. Courts do not consider applications filed after this deadline. The...
Back to Newsroom